Ontology highlight
ABSTRACT: Background
It is unclear whether circulating antibody levels conferred protection against SARS-CoV-2 infection among patients receiving dialysis during the Omicron-dominant period.Methods
We followed monthly semiquantitative SARS-CoV-2 RBD IgG index values in a randomly selected nationwide cohort of patients receiving dialysis and ascertained SARS-CoV-2 infection during the Omicron-dominant period of December 25, 2021 to January 31, 2022 using electronic health records. We estimated the relative risk for documented SARS-CoV-2 infection by vaccination status and by circulating RBD IgG using a log-binomial model accounting for age, sex, and prior COVID-19.Results
Among 3576 patients receiving dialysis, 901 (25%) received a third mRNA vaccine dose as of December 24, 20
SUBMITTER: Montez-Rath ME
PROVIDER: S-EPMC9528334 | biostudies-literature | 2022 Oct
REPOSITORIES: biostudies-literature